APA
Van Huis C. A., Bigge C. F., Casimiro-Garcia A., Cody W. L., Dudley D. A., Filipski K. J., Heemstra R. J., Kohrt J. T., Narasimhan L. S., Schaum R. P., Zhang E., Bryant J. W., Haarer S., Janiczek N., Leadley R. J., McClanahan T., Thomas Peterson J., Welch K. M. & Edmunds J. J. (20070905). Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors. : Chemical biology & drug design.
Chicago
Van Huis Chad A, Bigge Christopher F, Casimiro-Garcia Agustin, Cody Wayne L, Dudley Danette A, Filipski Kevin J, Heemstra Ronald J, Kohrt Jeffrey T, Narasimhan Lakshmi S, Schaum Robert P, Zhang Erli, Bryant John W, Haarer Staci, Janiczek Nancy, Leadley Robert J, McClanahan Thomas, Thomas Peterson J, Welch Kathleen M and Edmunds Jeremy J. 20070905. Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors. : Chemical biology & drug design.
Harvard
Van Huis C. A., Bigge C. F., Casimiro-Garcia A., Cody W. L., Dudley D. A., Filipski K. J., Heemstra R. J., Kohrt J. T., Narasimhan L. S., Schaum R. P., Zhang E., Bryant J. W., Haarer S., Janiczek N., Leadley R. J., McClanahan T., Thomas Peterson J., Welch K. M. and Edmunds J. J. (20070905). Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors. : Chemical biology & drug design.
MLA
Van Huis Chad A, Bigge Christopher F, Casimiro-Garcia Agustin, Cody Wayne L, Dudley Danette A, Filipski Kevin J, Heemstra Ronald J, Kohrt Jeffrey T, Narasimhan Lakshmi S, Schaum Robert P, Zhang Erli, Bryant John W, Haarer Staci, Janiczek Nancy, Leadley Robert J, McClanahan Thomas, Thomas Peterson J, Welch Kathleen M and Edmunds Jeremy J. Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors. : Chemical biology & drug design. 20070905.